The FDA has approved Mycamine (micafungin sodium injection, from Astellas Pharma) for the treatment of candidemia, acute disseminated candidiasis, and Candida peritonitis and abscesses. Mycamine, an echinocandin, is already indicated for the treatment of esophageal candidiasis and for the prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation.

For more information call (800) 727-7003 or visit